Related Experiment Video
Updated: Nov 9, 2025
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Accurate and Efficient Lipoprotein Detection Based on the HCR-DNAzyme Platform
Hua-Jie Chen1, Yusi Hu2, Peiyu Yao3
1Engineering Research Center of Nano-Geomaterials of Ministry of Education, Faculty of Materials Science and Chemistry, China University of Geosciences, Wuhan 430074, P. R. China.
This study introduces a novel, rapid method for directly measuring high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particle concentrations. This advance offers a more accurate way to assess cardiovascular disease risk by quantifying intact lipoprotein particles.
Area of Science:
- Biochemistry
- Molecular Diagnostics
- Cardiovascular Research
Background:
- Cardiovascular disease (CVD) is a leading global cause of mortality.
- Dyslipidemia, characterized by abnormal levels of high-density lipoprotein (HDL) and low-density lipoprotein (LDL), is a major risk factor for CVD.
- Current methods for assessing HDL and LDL particle levels are indirect, time-consuming, and labor-intensive, hindering accurate risk prediction.
Purpose of the Study:
- To develop an accurate and efficient method for the direct quantitative detection of intact high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particles.
- To overcome the limitations of traditional indirect methods for lipoprotein analysis.
- To provide a tool for improved cardiovascular disease risk assessment and clinical management.
Main Methods:
- Development of an enzyme- and isolation-free detection platform.
- Utilized DNAzyme and hybridization chain reaction (HCR) for signal amplification.
- Directly measured the concentration of intact HDL and LDL particles.
Main Results:
- Achieved limits of detection of 10 mg/dL for HDL and 30 mg/dL for LDL.
- Demonstrated the method's capability for analyzing lipoprotein concentrations in clinical samples.
- The HCR-DNAzyme platform provides direct and accurate quantification of lipoprotein particles, not just cholesterol content.
Conclusions:
- The novel HCR-DNAzyme method offers a direct, accurate, and efficient approach for quantifying HDL and LDL particles.
- This platform shows significant potential for clinical applications in diagnosing and managing dyslipidemia and cardiovascular disease.
- The developed assay facilitates improved health management through precise lipoprotein analysis.
